Vaccination alone is not sufficient to eliminate cervical cancer — critically analyse India's multi-pronged approach of vaccination, screening, and treatment.

Q. Vaccination alone is not sufficient to eliminate cervical cancer — critically analyse India's multi-pronged approach of vaccination, screening, and treatment. (15 marks, 250-350 words)

Cervical cancer is India's second most common cancer among women [2]. WHO's elimination strategy rests on three legs — 90% vaccination, 70% screening, 90% treatment by 2030 [3] — the benchmark against which India's 2026 HPV campaign must be assessed.

Pillar 1: Vaccination — strong start, narrow reach - Nationwide free, single-dose Gardasil-4 (quadrivalent) drive launched February 2026 from Ajmer for girls aged 14, validated by NTAGI [2]. - Over 52 lakh girls vaccinated by mid-July 2026 across all 36 States/UTs, tracked on the U-WIN platform [1]. - Limit: it protects only a future cohort. Women already exposed to HPV — the bulk of today's disease burden — gain nothing, so incidence will not fall for decades.

Pillar 2: Screening — the weakest link - Screening and early diagnosis are routed through Ayushman Arogya Mandirs and NP-NCD facilities [1]. - Limit: WHO's 70% target requires high-performance HPV-DNA testing twice by age 45 [3]; India relies largely on visual inspection at the primary level, with uneven trained-manpower availability and low female participation due to stigma.

Pillar 3: Treatment — capacity and continuum gaps - Day Care Cancer Centres at district level extend chemotherapy closer to patients [1]. - Limit: radiotherapy and oncology specialists remain concentrated in metros and tertiary institutes, so screen-positive rural women often drop out before treatment — breaking the referral chain.

Critical assessment - Strength: the design is a genuine continuum of care built on existing UIP and Ayushman Bharat architecture, with training completed in all States/UTs [1] — avoiding a standalone vertical scheme. - Weakness: the three pillars are unevenly resourced; vaccination is centrally driven and measurable, while screening and treatment depend on variable state health capacity.

India's approach is conceptually sound but sequentially unbalanced — prevention has outpaced detection and care. Sustaining momentum needs phased rollout of HPV-DNA screening, district-level oncology strengthening, and community mobilisation of ASHAs to convert coverage into cure. Achieved together, the 90-70-90 pathway can make cervical cancer India's first eliminated cancer, advancing SDG-3's promise of health for all.

(~330 words)

Sources: 1. Update on HPV Vaccination Programme and Cervical Cancer Prevention, Ministry of Health and Family Welfare, PIB (21 July 2026) — pib.gov.in — coverage figure of 52,10,302 girls, U-WIN tracking, delivery through Ayushman Arogya Mandirs and Day Care Cancer Centres, staff training across 36 States/UTs (exact release page could not be verified online; official domain cited) 2. Prime Minister Shri Narendra Modi Launches Nationwide HPV Vaccination Drive for 14-Year-Old Girls from Ajmer, Rajasthan, PIB (28 February 2026) — Gardasil-4 single dose, 14-year cohort, NTAGI validation, cervical cancer as second most common cancer among Indian women 3. WHO, Global Strategy to Accelerate the Elimination of Cervical Cancer as a Public Health Problem (2020) — 90-70-90 targets by 2030 and twice-lifetime high-performance screening standard